PZ Cormay S.A. (WSE:CRM)
Poland flag Poland · Delayed Price · Currency is PLN
0.5820
-0.0040 (-0.68%)
May 21, 2025, 3:27 PM CET
-6.73%
Market Cap 48.67M
Revenue (ttm) 92.02M
Net Income (ttm) -4.41M
Shares Out 84.21M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 49,152
Average Volume 102,768
Open 0.5920
Previous Close 0.5860
Day's Range 0.5620 - 0.5920
52-Week Range 0.3550 - 0.6300
Beta 1.02
RSI 59.13
Earnings Date May 16, 2025

About PZ Cormay

PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents in Poland. It offers testing products for clinical chemistry, electrophoresis, hematology, veterinary, coagulology, blood group serology, immunology, immunochemistry, molecular biology, sampling, oncological surgery, and general analytics, as well as vacuum blood collection system. The company offers its products under the Orphée and Diesse brand names. The company also exports its products to approximately 150 countries, including Germany, Austria, France, Greece, Turkey, Ind... [Read more]

Sector Technology
Founded 1985
Employees 825
Stock Exchange Warsaw Stock Exchange
Ticker Symbol CRM
Full Company Profile

Financial Performance

In 2024, PZ Cormay's revenue was 91.62 million, an increase of 11.43% compared to the previous year's 82.23 million. Losses were -5.27 million, 16.2% more than in 2023.

Financial Statements

News

There is no news available yet.